Program 2024
National Trauma Conference 2024 – Programme
Programme 2024
From our distinguished speakers…
Use of biomarkers in the management of trauma patients.
Presenter: Koji Morishita, MD, PhD
Trauma and Acute Critical Care Medical Center, Institution of Science Tokyo Hospital
Recent research has identified several potential biomarkers for trauma patients that could enhance diagnosis, prognosis, and treatment. These include cytokines and chemokines, microRNAs, metabolomic markers, extracellular vesicles (EVs), and damage-associated molecular patterns (DAMPs). Each of these biomarkers reflects different aspects of the body’s response to trauma, such as inflammation, gene expression changes, metabolic state, and cell damage. Exosomes, a type of EV, are particularly promising due to their stability and ability to carry molecular signatures of trauma, making them useful for non-invasive diagnostics. Previous research by our group demonstrated that lipid mediators in exosomes are one of the possible mechanisms of multiple organ dysfunction in post-traumatic injuries. I will introduce recently discovered biomarkers in trauma patient care.
Title: Hybrid Emergency Room System: a paradigm changes in polytrauma resuscitation
Presenter: Koji Morishita, MD, PhD
Trauma and Acute Critical Care Medical Center, Institution of Science Tokyo Hospital
Hybrid emergency room system (HERS) in Japan are advanced medical facilities that combine traditional emergency room functions with interventional radiology (IVR) and operation room. HERS is state-of-the-art technology.
HERS are designed to provide rapid diagnosis and treatment, particularly for critical conditions such as stroke, heart attack, and severe trauma.
Recently, HERS in Japan has improved the outcomes for severe trauma patients by reducing the time from arrival to CT, the time to IVR, and the required amount of blood transfusion.
In my presentation, I will introduce our HRES and its advantages and disadvantages.